Sex dimorphisms in activated mesenchymal stem cell function

Shock

Volumn 26, Issue 6, 2006, Pages 571-574

  Crisostomo, Paul R ^a   Wang, Meijing ^a   Herring, Christine M ^a   Morrell, Eric D ^a   Seshadri, Preethi ^a   Meldrum, Kirstan K ^a   Meldrum, Daniel R ^a,b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Emerson Hall 215 ^*  (United States)

Author keywords

MSC; TNF; VEGF

Indexed keywords

CD34 ANTIGEN; ENDOTOXIN; HYDROGEN PEROXIDE; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL ACTIVATION; CELL FUNCTION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HYPOXIA; INFLAMMATION; MALE; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; PARACRINE SIGNALING; SEX DIFFERENCE; STATISTICAL ANALYSIS;

ANIMALS; BONE MARROW CELLS; FEMALE; HYDROGEN PEROXIDE; LIPOPOLYSACCHARIDES; MALE; MESODERM; MICE; MICE, INBRED C57BL; SEX FACTORS; STEM CELLS; STROMAL CELLS; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33751254356     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.shk.0000233195.63859.ef     Document Type: Article

References (45)

1. Nagy RD, Tsai BM, Wang M, Markel TA, Brown JW, Meldrum DR: Stem cell transplantation as a therapeutic approach to organ failure. J Surg Res 129:152-160, 2005.
2. Orlic D, Hill JM, Arai AE: Stem cells for myocardial regeneration. Circ Res 91:1092-1102, 2002.
3. Kajstura J, Rota M, Whang B, Cascapera S, Hosoda T, Bearzi C, Nurzynska D, Kasahara H, Zias E, Bonafe M, et al: Bone marrow cells differentiate in cardiac cell lineages after infarction independently of cell fusion. Circ Res 96:127-137, 2005.
4. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR: Multilineage potential of adult human mesenchymal stem cells. Science 284:143-147, 1999.
5. Kawada H, Fujita J, Kinjo K, Matsuzaki Y, Tsuma M, Miyatake H, Muguruma Y, Tsuboi K, Itabashi Y, Ikeda Y, et al: Nonhematopoietic mesenchymal stem cells can be mobilized and differentiate into cardiomyocytes after myocardial infarction. Blood 104:3581-3587, 2004.
6. Amado LC, Saliaris AP, Schuleri KH, St John M, Xie JS, Cattaneo S, Durand DJ, Fitton T, Kuang JQ, Stewart G, et al: Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. Proc Natl Acad Sci U S A 102:11474-11479, 2005.
7. O'Neill TJt, Wamhoff BR, Owens GK, Skalak TC: Mobilization of bone marrow-derived cells enhances the angiogenic response to hypoxia without transdifferentiation into endothelial cells. Circ Res 97:1027-1035, 2005.
8. Murry CE, Soonpaa MH, Reinecke H, Nakajima H, Nakajima HO, Rubart M, Pasumarthi KB, Virag JI, Bartelmez SH, Poppa V, et al: Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 428:664-668, 2004.
9. Balsam LB, Wagers AJ, Christensen JL, Kofidis T, Weissman IL, Robbins RC: Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature 428:668-673, 2004.
10. Togel F, Hu Z, Weiss K, Isaac J, Lange C, Westenfelder C: Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms. Am J Physiol Renal Physiol 289:F31-F42, 2005.
11. Wang M, Tsai BM, Crisostomo PR, Meldrum DR: Pretreatment with adult progenitor cells improves recovery and decreases native myocardial proinflammatory signaling after ischemia. Shock 25:454-459, 2006.
12. Wang Y, Haider HK, Ahmad N, Xu M, Ge R, Ashraf M: Combining pharmacological mobilization with intramyocardial delivery of bone marrow cells over-expressing VEGF is more effective for cardiac repair. J Mol Cell Cardiol 40:736-745, 2006.
13. Werner N, Kosiol S, Schiegl T, Ahlers P, Walenta K, Link A, Bohm M, Nickenig G: Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 353:999-1007, 2005.
14. Meldrum DR: Tumor necrosis factor in the heart. Am J Physiol 274:R577-R595, 1998.
15. Pitcher JM, Tsai BM, Wang M, Kher A, Brown JW, Meldrum DR: Sexual dimorphism in myocardial tumor necrosis factor-alpha and cardiac function during endotoxin tolerance. Surgery 138:223-228, 2005.
16. Wang M, Baker L, Tsai BM, Meldrum KK, Meldrum DR: Sex differences in the myocardial inflammatory response to ischemia/reperfusion injury. Am J Physiol Endocrinol Metab 288:E321-E326, 2005.
17. Angele MK, Schwacha MG, Ayala A, Chaudry IH: Effect of gender and sex hormones on immune responses following shock. Shock 14:81-90, 2000.
18. Choudhry MA, Schwacha MG, Hubbard WJ, Kerby JD, Rue LW, Bland KI, Chaudry IH: Gender differences in acute response to trauma-hemorrhage. Shock 24(suppl 1):101-106, 2005.
19. Prockop DJ: Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 276:71-74, 1997.
20. Ryan JM, Barry FP, Murphy JM, Mahon BP: Mesenchymal stem cells avoid allogeneic rejection. J Inflamm (Lond) 2:8, 2005.
21. Peister A, Mellad JA, Larson BL, Hall BM, Gibson LF, Prockop DJ: Adult stem cells from bone marrow (MSCs) isolated from different strains of inbred mice vary in surface epitopes, rates of proliferation, and differentiation potential. Blood 103:1662-1668, 2004.
22. Persky AM, Green PS, Stubley L, Howell CO, Zaulyanov L, Brazeau GA, Simpkins JW: Protective effect of estrogens against oxidative damage to heart and skeletal muscle in vivo and in vitro. Proc Soc Exp Biol Med 223:59-66, 2000.
23. Dernbach E, Urbich C, Brandes RP, Hofmann WK, Zeiher AM, Dimmeler S: Antioxidative stress-associated genes in circulating progenitor cells: evidence for enhanced resistance against oxidative stress. Blood 104:3591-3597, 2004.
24. Ramalho-Santos M, Yoon S, Matsuzaki Y, Mulligan RC, Melton DA: "Stemness": transcriptional profiling of embryonic and adult stem cells. Science 298:597-600, 2002.
25. Rehman J, Traktuev D, Li J, Merfeld-Clauss S, Temm-Grove CJ, Bovenkerk JE, Pell CL, Johnstone BH, Considine RV, March KL: Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells. Circulation 109:1292-1298, 2004.
26. Hiasa K, Egashira K, Kitamoto S, Ishibashi M, Inoue S, Ni W, Zhao Q, Nagata S, Katoh M, Sata M, et al: Bone marrow mononuclear cell therapy limits myocardial infarct size through vascular endothelial growth factor. Basic Res Cardiol 99:165-172, 2004.
27. Tang YL, Zhao Q, Zhang YC, Cheng L, Liu M, Shi J, Yang YZ, Pan C, Ge J, Phillips MI: Autologous mesenchymal stem cell transplantation induce VEGF and neovascularization in ischemic myocardium. Regul Pept 117:3-10, 2004.
28. Rossouw JE: Hormones, genetic factors, and gender differences in cardiovascular disease. Cardiovasc Res 53:550-557, 2002.
29. Baker L, Meldrum KK, Wang M, Sankula R, Vanam R, Raiesdana A, Tsai BM, Hile K, Brown JW, Meldrum DR: The role of estrogen in cardiovascular disease. J Surg Res 115:325-344, 2003.
30. Szalay L, Shimizu T, Schwacha MG, Choudhry MA, Rue LW 3rd, Bland KI, Chaudry IH: Mechanism of salutary effects of estradiol on organ function after trauma-hemorrhage: upregulation of heme oxygenase. Am J Physiol Heart Circ Physiol 289:H92-H98, 2005.
31. Mizushima Y, Wang P, Jarrar D, Cioffi WG, Bland KI, Chaudry IH: Estradiol administration after trauma-hemorrhage improves cardiovascular and hepatocellular functions in male animals. Ann Surg 232:673-679, 2000.
32. Horton JW, White DJ, Maass DL: Gender-related differences in myocardial inflammatory and contractile responses to major burn trauma. Am J Physiol Heart Circ Physiol 286:H202-H213, 2004.
33. Schwacha MG, Holland LT, Chaudry IH, Messina JL: Genetic variability in the immune-inflammatory response after major burn injury. Shock 23:123-128, 2005.
34. Kuebler JF, Toth B, Rue LW 3rd, Wang P, Bland KI, Chaudry IH: Differential fluid regulation during and after soft tissue trauma and hemorrhagic shock in males and proestrus females. Shock 20:144-148, 2003.
35. Cavasin MA, Tao Z, Menon S, Yang XP: Gender differences in cardiac function during early remodeling after acute myocardial infarction in mice. Life Sci 75:2181-2192, 2004.
36. Rauscher FM, Goldschmidt-Clermont PJ, Davis BH, Wang T, Gregg D, Ramaswami P, Pippen AM, Annex BH, Dong C, Taylor DA: Aging, progenitor cell exhaustion, and atherosclerosis. Circulation 108:457-463, 2003.
37. Hodis HN, Mack WJ, Lobo RA, Shoupe D, Sevanian A, Mahrer PR, Selzer RH, Liu Cr CR, Liu Ch CH, Azen SP: Estrogen in the prevention of atherosclerosis. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 135:939-953, 2001.
38. Mendelsohn ME, Karas RH: The protective effects of estrogen on the cardiovascular system. N Engl J Med 340:1801-1811, 1999.
39. Szalay L, Shimizu T, Suzuki T, Yu HP, Choudhry MA, Schwacha MG, Rue LW 3rd, Bland KI, Chaudry IH: Estradiol improves cardiac and hepatic function after trauma-hemorrhage: role of enhanced heat shock protein expression. Am J Physiol Regul Integr Comp Physiol 290:R812-R818, 2006.
40. Yu HP, Shimizu T, Choudhry MA, Hsieh YC, Suzuki T, Bland KI, Chaudry IH: Mechanism of cardioprotection following trauma-hemorrhagic shock by a selective estrogen receptor-beta agonist: up-regulation of cardiac heat shock factor-1 and heat shock proteins. J Mol Cell Cardiol 40:185-194, 2006.
41. Yu HP, Shimizu T, Hsieh YC, Suzuki T, Choudhry MA, Schwacha MG, Chaudry IH: Tissue-specific expression of estrogen receptors and their role in the regulation of neutrophil infiltration in various organs following traumahemorrhage. J Leukoc Biol 79:963-970, 2006.
42. Wang M, Crisostomo P, Wairiuko GM, Meldrum DR: Estrogen receptor-alpha mediates acute myocardial protection in females. Am J Physiol Heart Circ Physiol 290:H2204-H2209, 2006.
43. Wang M, Tsai BM, Reiger KM, Brown JW, Meldrum DR: 17-beta-Estradiol decreases p38 MAPK-mediated myocardial inflammation and dysfunction following acute ischemia. J Mol Cell Cardiol 40:205-212, 2006.
44. Yokoyama Y, Nimura Y, Nagino M, Bland KI, Chaudry IH: Current understanding of gender dimorphism in hepatic pathophysiology. J Surg Res 128:147-156, 2005.
45. Dribben W, Nemmers B, Nardi A, Taylor G, Olney J, Farber N: Chronic but not acute estradiol treatment protects against the neurodegenerative effects of N-methyl-D-aspartate receptor antagonists. Endocrine 21:53-58, 2003.